The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Recombinant Monoclonal Antibody Market Research Report 2025
Synopsis
The global Recombinant Monoclonal Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Recombinant Monoclonal Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant Monoclonal Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Recombinant Monoclonal Antibody include Abcam, Boster Bio, Evitria, Novus Biologicals, ACROBiosystems, Abyntek Biopharma, Sino Biological and Enzo Life Sciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Monoclonal Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Monoclonal Antibody.
Report Scope
The Recombinant Monoclonal Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Monoclonal Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Monoclonal Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
Boster Bio
Evitria
Novus Biologicals
ACROBiosystems
Abyntek Biopharma
Sino Biological
Enzo Life Sciences
Segment by Type
Humanized Antibodies
Small Molecule Antibody
Other
Segment by Application
Immunohistochemistry
Western Blot
Immunofluorescence
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Monoclonal Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Monoclonal Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Recombinant Monoclonal Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Recombinant Monoclonal Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant Monoclonal Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Recombinant Monoclonal Antibody include Abcam, Boster Bio, Evitria, Novus Biologicals, ACROBiosystems, Abyntek Biopharma, Sino Biological and Enzo Life Sciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Monoclonal Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Monoclonal Antibody.
Report Scope
The Recombinant Monoclonal Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Monoclonal Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Monoclonal Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
Boster Bio
Evitria
Novus Biologicals
ACROBiosystems
Abyntek Biopharma
Sino Biological
Enzo Life Sciences
Segment by Type
Humanized Antibodies
Small Molecule Antibody
Other
Segment by Application
Immunohistochemistry
Western Blot
Immunofluorescence
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Monoclonal Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Monoclonal Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Recombinant Monoclonal Antibody Market Overview
1.1 Product Overview and Scope of Recombinant Monoclonal Antibody
1.2 Recombinant Monoclonal Antibody Segment by Type
1.2.1 Global Recombinant Monoclonal Antibody Market Value Comparison by Type (2024-2030)
1.2.2 Humanized Antibodies
1.2.3 Small Molecule Antibody
1.2.4 Other
1.3 Recombinant Monoclonal Antibody Segment by Application
1.3.1 Global Recombinant Monoclonal Antibody Market Value by Application: (2024-2030)
1.3.2 Immunohistochemistry
1.3.3 Western Blot
1.3.4 Immunofluorescence
1.3.5 Other
1.4 Global Recombinant Monoclonal Antibody Market Size Estimates and Forecasts
1.4.1 Global Recombinant Monoclonal Antibody Revenue 2019-2030
1.4.2 Global Recombinant Monoclonal Antibody Sales 2019-2030
1.4.3 Global Recombinant Monoclonal Antibody Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Recombinant Monoclonal Antibody Market Competition by Manufacturers
2.1 Global Recombinant Monoclonal Antibody Sales Market Share by Manufacturers (2019-2024)
2.2 Global Recombinant Monoclonal Antibody Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Recombinant Monoclonal Antibody Average Price by Manufacturers (2019-2024)
2.4 Global Recombinant Monoclonal Antibody Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Monoclonal Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Monoclonal Antibody, Product Type & Application
2.7 Recombinant Monoclonal Antibody Market Competitive Situation and Trends
2.7.1 Recombinant Monoclonal Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Recombinant Monoclonal Antibody Players Market Share by Revenue
2.7.3 Global Recombinant Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant Monoclonal Antibody Retrospective Market Scenario by Region
3.1 Global Recombinant Monoclonal Antibody Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Recombinant Monoclonal Antibody Global Recombinant Monoclonal Antibody Sales by Region: 2019-2030
3.2.1 Global Recombinant Monoclonal Antibody Sales by Region: 2019-2024
3.2.2 Global Recombinant Monoclonal Antibody Sales by Region: 2025-2030
3.3 Global Recombinant Monoclonal Antibody Global Recombinant Monoclonal Antibody Revenue by Region: 2019-2030
3.3.1 Global Recombinant Monoclonal Antibody Revenue by Region: 2019-2024
3.3.2 Global Recombinant Monoclonal Antibody Revenue by Region: 2025-2030
3.4 North America Recombinant Monoclonal Antibody Market Facts & Figures by Country
3.4.1 North America Recombinant Monoclonal Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Recombinant Monoclonal Antibody Sales by Country (2019-2030)
3.4.3 North America Recombinant Monoclonal Antibody Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Monoclonal Antibody Market Facts & Figures by Country
3.5.1 Europe Recombinant Monoclonal Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Recombinant Monoclonal Antibody Sales by Country (2019-2030)
3.5.3 Europe Recombinant Monoclonal Antibody Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Recombinant Monoclonal Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific Recombinant Monoclonal Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Recombinant Monoclonal Antibody Sales by Country (2019-2030)
3.6.3 Asia Pacific Recombinant Monoclonal Antibody Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Recombinant Monoclonal Antibody Market Facts & Figures by Country
3.7.1 Latin America Recombinant Monoclonal Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Recombinant Monoclonal Antibody Sales by Country (2019-2030)
3.7.3 Latin America Recombinant Monoclonal Antibody Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Recombinant Monoclonal Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Monoclonal Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Recombinant Monoclonal Antibody Sales by Country (2019-2030)
3.8.3 Middle East and Africa Recombinant Monoclonal Antibody Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Monoclonal Antibody Sales by Type (2019-2030)
4.1.1 Global Recombinant Monoclonal Antibody Sales by Type (2019-2024)
4.1.2 Global Recombinant Monoclonal Antibody Sales by Type (2025-2030)
4.1.3 Global Recombinant Monoclonal Antibody Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Monoclonal Antibody Revenue by Type (2019-2030)
4.2.1 Global Recombinant Monoclonal Antibody Revenue by Type (2019-2024)
4.2.2 Global Recombinant Monoclonal Antibody Revenue by Type (2025-2030)
4.2.3 Global Recombinant Monoclonal Antibody Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Monoclonal Antibody Price by Type (2019-2030)
5 Segment by Application
5.1 Global Recombinant Monoclonal Antibody Sales by Application (2019-2030)
5.1.1 Global Recombinant Monoclonal Antibody Sales by Application (2019-2024)
5.1.2 Global Recombinant Monoclonal Antibody Sales by Application (2025-2030)
5.1.3 Global Recombinant Monoclonal Antibody Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Monoclonal Antibody Revenue by Application (2019-2030)
5.2.1 Global Recombinant Monoclonal Antibody Revenue by Application (2019-2024)
5.2.2 Global Recombinant Monoclonal Antibody Revenue by Application (2025-2030)
5.2.3 Global Recombinant Monoclonal Antibody Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Monoclonal Antibody Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abcam
6.1.1 Abcam Corporation Information
6.1.2 Abcam Description and Business Overview
6.1.3 Abcam Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abcam Recombinant Monoclonal Antibody Product Portfolio
6.1.5 Abcam Recent Developments/Updates
6.2 Boster Bio
6.2.1 Boster Bio Corporation Information
6.2.2 Boster Bio Description and Business Overview
6.2.3 Boster Bio Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boster Bio Recombinant Monoclonal Antibody Product Portfolio
6.2.5 Boster Bio Recent Developments/Updates
6.3 Evitria
6.3.1 Evitria Corporation Information
6.3.2 Evitria Description and Business Overview
6.3.3 Evitria Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Evitria Recombinant Monoclonal Antibody Product Portfolio
6.3.5 Evitria Recent Developments/Updates
6.4 Novus Biologicals
6.4.1 Novus Biologicals Corporation Information
6.4.2 Novus Biologicals Description and Business Overview
6.4.3 Novus Biologicals Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novus Biologicals Recombinant Monoclonal Antibody Product Portfolio
6.4.5 Novus Biologicals Recent Developments/Updates
6.5 ACROBiosystems
6.5.1 ACROBiosystems Corporation Information
6.5.2 ACROBiosystems Description and Business Overview
6.5.3 ACROBiosystems Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.5.4 ACROBiosystems Recombinant Monoclonal Antibody Product Portfolio
6.5.5 ACROBiosystems Recent Developments/Updates
6.6 Abyntek Biopharma
6.6.1 Abyntek Biopharma Corporation Information
6.6.2 Abyntek Biopharma Description and Business Overview
6.6.3 Abyntek Biopharma Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Abyntek Biopharma Recombinant Monoclonal Antibody Product Portfolio
6.6.5 Abyntek Biopharma Recent Developments/Updates
6.7 Sino Biological
6.6.1 Sino Biological Corporation Information
6.6.2 Sino Biological Description and Business Overview
6.6.3 Sino Biological Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sino Biological Recombinant Monoclonal Antibody Product Portfolio
6.7.5 Sino Biological Recent Developments/Updates
6.8 Enzo Life Sciences
6.8.1 Enzo Life Sciences Corporation Information
6.8.2 Enzo Life Sciences Description and Business Overview
6.8.3 Enzo Life Sciences Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Enzo Life Sciences Recombinant Monoclonal Antibody Product Portfolio
6.8.5 Enzo Life Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Monoclonal Antibody Industry Chain Analysis
7.2 Recombinant Monoclonal Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Monoclonal Antibody Production Mode & Process
7.4 Recombinant Monoclonal Antibody Sales and Marketing
7.4.1 Recombinant Monoclonal Antibody Sales Channels
7.4.2 Recombinant Monoclonal Antibody Distributors
7.5 Recombinant Monoclonal Antibody Customers
8 Recombinant Monoclonal Antibody Market Dynamics
8.1 Recombinant Monoclonal Antibody Industry Trends
8.2 Recombinant Monoclonal Antibody Market Drivers
8.3 Recombinant Monoclonal Antibody Market Challenges
8.4 Recombinant Monoclonal Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
